Hear what our attorneys are saying

31
May 2019

Setting Reserves in the Wake of the Appellate Court Decision in Pisano

By Micaela Cassidy     

  On December 7, 2018, the Appellate Court of Illinois issued a Decision in William Pisano v. The Illinois Workers’ Compensation Commission (City of Chicago), 2018 IL App (1st) 172712WC, which sheds further light on awards for permanent partial disability in cases where multiple accidents and injuries are at issue, and a wage loss results
Read the full article…

Read More
30
May 2019

IWCC Medical Fee Advisory Board Proposes Rules Defining “Explanation of Benefits”

By Joseph Gregorio     

  On May 20, 2019, the Illinois Workers’ Compensation Medical Fee Advisory Board announced a Proposed Amendment to the Workers’ Compensation Commission’s Administrative Rules.  The proposed rules will help employers and providers navigate some of the changes implemented to the medical bill processes implemented last year by Senate Bill 904. In November 2018, Public Act
Read the full article…

Read More
23
May 2019

LEGISLATIVE ALERT – The Effect of Passage of Public Act 101-6 on the Business Community.

By Padraig McCoid     

  On May 17, 2019, Illinois Governor Pritzker signed SB 1596 into law as Public Act 101-6. The law amends the Illinois Workers’ Compensation Act (“WC Act”) and Occupational Diseases Act (“OD Act”).  SB 1596 provides that provisions of the WC and OD Acts “limiting recovery do not apply to injuries or death resulting from
Read the full article…

Read More
30
Apr 2019

Confounded About Compounded Medications? A Primer for Claims Management

By Julie A. Garrison     

  Compounded Medications and Their Uses: Compounding is when a licensed pharmacist combines, mixes or alters at least two ingredients to create a medication tailored to an individual patient. Compounding pharmacies are not regulated by the Food and Drug Administration and thus, compounded medications are exempt from FDA approval. There are legitimate reasons to use
Read the full article…

Read More
24
Apr 2019

Answers by Amy

By Amy Bilton     

  A few months ago, we submitted an MSA in a case where Lyrica was being prescribed “off-label” for a diagnosis of lumbar radiculopathy.  CMS included it in the MSA.  The inclusion of Lyrica inflated the MSA astronomically, and nearly prevented the case from settling.  I received this question:  “How can the rules just change
Read the full article…

Read More